Ilex Medical
Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally. Based in Petah Tikva.
Ilex Medical: net income sharply down (−64.0%), sales down (−9.9%), operating income sharply down (−50.6%).
- Net income sharply downH1 2026
Net income: ₪9M, vs. ₪26M a year earlier, i.e. −64.0%.
- Sales downH1 2026
Revenue: ₪412M, vs. ₪458M a year earlier, i.e. −9.9%.
- Operating income sharply downH1 2026
Operating income: ₪14M, vs. ₪27M a year earlier, i.e. −50.6%.
- Cash flow sharply upH1 2026
Operating cash flow: ₪73M, vs. ₪60M a year earlier, i.e. +21.7%.
What the market pays, vs. the sector
This company's valuation multiples history is being built day by day from now on.
P/E calculated on net income (trailing 12 months: last fiscal year + H1 2026 − same period a year earlier). Sector median: companies in the group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.
Dividend per share, over 5 years
Total dividends per share paid each calendar year (5 year(s) out of 5 with a payment). Source: Yahoo Finance. The current year is not complete.
Follow earnings · WhatsApp group TA-125Details ▾
Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.
Join the TA-125 groupDetailed figures and history
Financial summary
| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Total assets | 956 | 947 | 993 |
| Current assets | 631 | 675 | 724 |
| Non-current assets | 325 | 272 | 269 |
| Equity | 670 | 660 | 685 |
| of which minority interests | 0 | 0 | 0 |
| Current liabilities | 206 | 219 | 255 |
| Non-current liabilities | 80 | 68 | 53 |
| Revenue | 412 | 458 | 931 |
| Gross profit | 90 | 105 | 212 |
| Operating income | 14 | 27 | 63 |
| Pre-tax income | 14 | 35 | 74 |
| Net income | 9 | 26 | 56 |
| Net income (attributable to shareholders) | 9 | 26 | 56 |
| Dividends paid | −22 | −14 | −14 |
| Operating cash flow | 73 | 60 | 73 |
In millions of shekels. The "H1" columns cover the first six months of the year.
Calculated from these figures
| S1 2026 | S1 2025 | FY 2025 | |
|---|---|---|---|
| Gross margin | 21.9% | 22.8% | 22.8% |
| Operating margin | 3.3% | 6.0% | 6.8% |
| Net margin | 2.3% | 5.7% | 6.0% |
| Current ratio (current assets / current liabilities) | 3,1 x | 3,1 x | 2,8 x |
| Equity / total assets | 70.1% | 69.7% | 69.0% |
The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.
Company overview
Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally. The company also provides laboratory services, as well as is involved in the development, production, marketing and sale of software systems for information management in medical laboratories. Its products are used for performing tests in hospital medical laboratories, blood banks and health insurance funds, as well as for providing application and technical services to users. Ilex Medical Ltd was incorporated in 1990 and is based in Petah Tikva, Israel.
Source: official company profile (Yahoo Finance), summary. Website: www.ilexmedical.com
- Maya, Tel Aviv Stock Exchange: company page and reports